Literature DB >> 12042582

Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan.

Luan-Yin Chang1, Chwan-Chuen King, Kuang-Hung Hsu, Hsiao-Chen Ning, Kuo-Chien Tsao, Chung-Chen Li, Yhu-Chering Huang, Shin-Ru Shih, Shu-Ti Chiou, Po-Yen Chen, Hong-Jen Chang, Tzou-Yien Lin.   

Abstract

OBJECTIVE: In 1998, an enterovirus 71 (EV71) epidemic in Taiwan was associated with hand, foot, and mouth disease (HFMD)/herpangina and involved 78 fatal cases. We measured EV71 seroprevalence rates before and after the epidemic and investigated risk factors associated with EV71 infection and illness.
METHODS: Neutralizing antibodies to EV71 were assayed for 539 people before the epidemic and 4619 people of similar ages after the epidemic. Questionnaires, which were completed during household interviews after the epidemic, solicited demographic variables, exposure history, and clinical manifestations.
RESULTS: A total of 129 106 cases of HFMD were reported during the epidemic. Age-specific pre-epidemic EV71 seroprevalence rates were inversely related to age-specific periepidemic mortality rates (r = -0.82) or severe case rates (r = -0.93). Higher postepidemic EV71 seropositive rates among children who were younger than 3 years positively correlated with higher mortality rates in different areas (r = 0.88). After the epidemic, 51 (56%) of 91 younger siblings of elder siblings who were EV71-seropositive were EV71-seropositive; otherwise, 2.2% (4 of 186) of younger siblings were EV71-seropositive (matched odds ratio [OR]: 10; 95% confidence interval [CI]: 3.4-29). Stepwise multiple logistic regression revealed other factors associated with EV71 infection to be older age (adjusted OR: 2.5; 95% CI: 1.9-3.4), attendance at kindergartens/child care centers (adjusted OR: 1.8; 95% CI: 1.3-2.5), contact with HFMD/herpangina (adjusted OR: 1.6; 95% CI: 1.2-2.1), greater number of children in a family (adjusted OR: 1.4; 95% CI: 1.1-1.7), and rural residence (adjusted OR: 1.4; 95% CI: 1.2-1.6). Twenty-nine percent of preschool children who were infected with EV71 developed HFMD/herpangina. Younger age and contact with HFMD/herpangina were significant factors for the development of EV71-related HFMD/herpangina in these children.
CONCLUSIONS: An increased incidence of EV71 infection in young children occurred more often in geographic areas with increased mortality rates. Intrafamilial and kindergarten transmissions among preschool children were major modes of disease transmission during the widespread EV71 epidemic in Taiwan in 1998.

Entities:  

Mesh:

Year:  2002        PMID: 12042582     DOI: 10.1542/peds.109.6.e88

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  101 in total

1.  Forecasting the economic value of an Enterovirus 71 (EV71) vaccine.

Authors:  Bruce Y Lee; Angela R Wateska; Rachel R Bailey; Julie H Y Tai; Kristina M Bacon; Kenneth J Smith
Journal:  Vaccine       Date:  2010-10-16       Impact factor: 3.641

2.  Validation and evaluation of serological correlates of protection for inactivated enterovirus 71 vaccine in children aged 6-35 months.

Authors:  Pengfei Jin; Jingxin Li; Xuefeng Zhang; Fangyue Meng; Yang Zhou; Xuejun Yao; Zhengkai Gan; Fengcai Zhu
Journal:  Hum Vaccin Immunother       Date:  2016-01-11       Impact factor: 3.452

3.  Neutralizing activity induced by the attenuated coxsackievirus B3 Sabin3-like strain against CVB3 infection.

Authors:  Nadia Jrad-Battikh; Amira Souii; Leila Oueslati; Mahjoub Aouni; Didier Hober; Jawhar Gharbi; Manel Ben M'hadheb-Gharbi
Journal:  Curr Microbiol       Date:  2013-12-10       Impact factor: 2.188

4.  Prevalence of nonpolio enteroviruses in the sewage of Guangzhou city, China, from 2009 to 2012.

Authors:  Huanying Zheng; Jing Lu; Yong Zhang; Hiromu Yoshida; Xue Guo; Leng Liu; Hui Li; Hanri Zeng; Ling Fang; Yanling Mo; Lina Yi; Toru Chosa; Wenbo Xu; Changwen Ke
Journal:  Appl Environ Microbiol       Date:  2013-10-04       Impact factor: 4.792

5.  Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene.

Authors:  Kok Keng Tee; Tommy Tsan-Yuk Lam; Yoke Fun Chan; Jon M Bible; Adeeba Kamarulzaman; C Y William Tong; Yutaka Takebe; Oliver G Pybus
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

6.  Estimating the Severity Profile of Enterovirus A71 Infections in Children: A Bayesian Synthesis Framework.

Authors:  Bingyi Yang; Eric H Y Lau; Benjamin J Cowling
Journal:  Am J Epidemiol       Date:  2019-02-01       Impact factor: 4.897

Review 7.  Progress on the research and development of human enterovirus 71 (EV71) vaccines.

Authors:  Zhenglun Liang; Qunying Mao; Fan Gao; Junzhi Wang
Journal:  Front Med       Date:  2012-12-17       Impact factor: 4.592

8.  Retrospective seroepidemiology indicated that human enterovirus 71 and coxsackievirus A16 circulated wildly in central and southern China before large-scale outbreaks from 2008.

Authors:  Zhen Zhu; Shuangli Zhu; Xuebin Guo; Jitao Wang; Dongyan Wang; Dongmei Yan; Xiaojuan Tan; Liuying Tang; Hui Zhu; Zhaohui Yang; Xiaohong Jiang; Yixin Ji; Yong Zhang; Wenbo Xu
Journal:  Virol J       Date:  2010-11-04       Impact factor: 4.099

Review 9.  Coxsackievirus A16: epidemiology, diagnosis, and vaccine.

Authors:  Qunying Mao; Yiping Wang; Xin Yao; Lianlian Bian; Xing Wu; Miao Xu; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2013-11-14       Impact factor: 3.452

10.  Enterovirus 71 maternal antibodies in infants, Taiwan.

Authors:  Shu Ting Luo; Pai Shan Chiang; An Shine Chao; Guan Yuan Liou; Reyin Lin; Tzou Yien Lin; Min Shi Lee
Journal:  Emerg Infect Dis       Date:  2009-04       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.